0001209191-19-021050.txt : 20190322
0001209191-19-021050.hdr.sgml : 20190322
20190322172243
ACCESSION NUMBER: 0001209191-19-021050
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190322
FILED AS OF DATE: 20190322
DATE AS OF CHANGE: 20190322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cearnal Martin E
CENTRAL INDEX KEY: 0001408500
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33637
FILM NUMBER: 19700742
MAIL ADDRESS:
STREET 1: 31 UPPER MOUNTAIN AVENUE
STREET 2: APARTMENT 2
CITY: MONTCLAIR
STATE: NJ
ZIP: 07042
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001087294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE,
STATE: TN
ZIP: 37203
BUSINESS PHONE: 615-255-0068
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-22
0
0001087294
CUMBERLAND PHARMACEUTICALS INC
CPIX
0001408500
Cearnal Martin E
2525 WEST END AVE.
SUITE 950
NASHVILLE
TN
37203
1
1
0
0
Sr VP/Chief Commercial Officer
Common Stock
2019-03-22
4
A
0
5000
5.98
A
149667
D
Common Stock
2019-03-22
4
F
0
1250
5.62
D
148417
D
Restricted stock award will vest 100% on March 18, 2023.
This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.
Martin E. Cearnal by /s/ Michael Bonner as attorney-in-fact
2019-03-22